You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
三生國健(688336.SH)拉昇封漲停板 已連續第六日上漲
格隆匯 05-18 13:54
格隆匯5月18日丨創新藥板塊午後集體拉昇,其中,三生國健(688336.SH)拉昇封漲停板,報20.82元,該股已連續第六日上漲,累漲31%,最新市值128億元。公司12日公佈,收到國家藥監局核准簽發的《藥物臨牀試驗批准通知書》,同意一項評價CPGJ602聯合伊尼妥單抗及化療在HER2陽性且KRAS、NRAS 和BRAF野生型的轉移性結直腸癌患者中有效性和安全性的Ⅰb/Ⅱ期臨牀研究,並將於近期開展臨牀試驗。本次臨牀試驗是抗EGFR和抗HER2雙重靶向療法的探索性臨牀試驗,是目前中國區域內首個獲得NMPA批准的抗HER2及抗EGFR大分子生物藥聯合治療的臨牀試驗。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account